
Company News
A look at Tscan Therapeutics Inc’s (TCRX) recent performance gives investors their first glimpse of hope.
On Tuesday, Tscan Therapeutics Inc (NASDAQ: TCRX) was 19.86% up from the session before settling in for the closing price of $1.46. A 52-week range